These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

642 related items for PubMed ID: 23731387

  • 1. Cytomegalovirus infection post-pancreas-kidney transplantation--results of antiviral prophylaxis in high-risk patients.
    Fallatah SM, Marquez MA, Bazerbachi F, Schiff JR, Cattral MS, McGilvray ID, Norgate A, Selzner M, Rotstein C, Husain S.
    Clin Transplant; 2013; 27(4):503-9. PubMed ID: 23731387
    [Abstract] [Full Text] [Related]

  • 2. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ, Malaise J, Moreno A, Crespo M, Fernández-Cruz L, Euro-SPK Study Group.
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [Abstract] [Full Text] [Related]

  • 3. Epidemiology of cytomegalovirus infection after pancreas transplantation.
    Parsaik AK, Bhalla T, Dong M, Rostambeigi N, Dierkhising RA, Dean P, Abraham R, Prieto M, Kremers WK, Razonable RR, Kudva YC.
    Transplantation; 2011 Nov 15; 92(9):1044-50. PubMed ID: 21904269
    [Abstract] [Full Text] [Related]

  • 4. Incidence and outcomes of cytomegalovirus in pancreas transplantation with steroid-free immunosuppression.
    Shah AP, Chen JM, Fridell JA.
    Clin Transplant; 2015 Dec 15; 29(12):1221-9. PubMed ID: 26458498
    [Abstract] [Full Text] [Related]

  • 5. Long-term outcome of cytomegalovirus infection in simultaneous pancreas-kidney transplant recipients without ganciclovir prophylaxis.
    Rayes N, Seehofer D, Kahl A, Kokott S, Pratschke J, Frei U, Neuhaus P.
    Transpl Int; 2007 Nov 15; 20(11):974-81. PubMed ID: 17680782
    [Abstract] [Full Text] [Related]

  • 6. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
    Becker BN, Becker YT, Leverson GE, Simmons WD, Sollinger HW, Pirsch JD.
    Am J Kidney Dis; 2002 May 15; 39(5):1088-95. PubMed ID: 11979354
    [Abstract] [Full Text] [Related]

  • 7. Risk factors and impact of cytomegalovirus disease in simultaneous pancreas-kidney transplantation.
    Kaufman DB, Leventhal JR, Gallon LG, Parker MA, Koffron AJ, Fryer JP, Abecassis MM, Stuart FP.
    Transplantation; 2001 Dec 27; 72(12):1940-5. PubMed ID: 11773893
    [Abstract] [Full Text] [Related]

  • 8. Clinical outcome with low-dose valacyclovir in high-risk renal transplant recipients: a 10-year experience.
    Sund F, Tufveson G, Döhler B, Opelz G, Eriksson BM.
    Nephrol Dial Transplant; 2013 Mar 27; 28(3):758-65. PubMed ID: 23243043
    [Abstract] [Full Text] [Related]

  • 9. Cytomegalovirus infection in simultaneous pancreas-kidney transplantation.
    Malaise J, Ricart MJ, Moreno A, Crespo M, Fernández-Cruz L, Van Ophem D, Squifflet JP, EUROSPK Study Group.
    Transplant Proc; 2005 Mar 27; 37(6):2848-50. PubMed ID: 16182830
    [Abstract] [Full Text] [Related]

  • 10. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.
    Razonable RR, Rivero A, Rodriguez A, Wilson J, Daniels J, Jenkins G, Larson T, Hellinger WC, Spivey JR, Paya CV.
    J Infect Dis; 2001 Dec 01; 184(11):1461-4. PubMed ID: 11709790
    [Abstract] [Full Text] [Related]

  • 11. Preemptive therapy is not adequate for prevention of cytomegalovirus disease in pancreas-kidney transplant recipients.
    López-Medrano F, Rueda B, Lizasoain M, Juan RS, Folgueira D, Andrés A, Morales JM, Jiménez C, Meneu JC, Aguado JM.
    Transpl Infect Dis; 2009 Oct 01; 11(5):400-4. PubMed ID: 19570139
    [Abstract] [Full Text] [Related]

  • 12. Cytomegalovirus serostatus pairing and deceased donor kidney transplant outcomes in adult recipients with antiviral prophylaxis.
    Kuo HT, Ye X, Sampaio MS, Reddy P, Bunnapradist S.
    Transplantation; 2010 Nov 27; 90(10):1091-8. PubMed ID: 20885340
    [Abstract] [Full Text] [Related]

  • 13. [The significance of risk-adapted antiviral prophylaxis and modern virus diagnosis for organ survival after kidney transplantation].
    Fricke L, Steinhoff J, Hartwig-Weber I, Bein G.
    Dtsch Med Wochenschr; 1997 May 02; 122(18):565-71. PubMed ID: 9190308
    [Abstract] [Full Text] [Related]

  • 14. Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma: a multicentre retrospective analysis.
    Opelz G, Daniel V, Naujokat C, Fickenscher H, Döhler B.
    Lancet Oncol; 2007 Mar 02; 8(3):212-8. PubMed ID: 17329191
    [Abstract] [Full Text] [Related]

  • 15. Pharmacoepidemiology of cytomegalovirus prophylaxis in a large retrospective cohort of kidney transplant recipients with Medicare Part D coverage.
    Santos CA, Brennan DC, Saeed MJ, Fraser VJ, Olsen MA.
    Clin Transplant; 2016 Apr 02; 30(4):435-44. PubMed ID: 26841129
    [Abstract] [Full Text] [Related]

  • 16. Comparing cytomegalovirus prophylaxis in renal transplantation: single center experience.
    Varga M, Remport A, Hídvégi M, Péter A, Kóbori L, Telkes G, Fazakas J, Gerlei Z, Sárváry E, Sulyok B, Járay J.
    Transpl Infect Dis; 2005 Jun 02; 7(2):63-7. PubMed ID: 16150092
    [Abstract] [Full Text] [Related]

  • 17. The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients.
    Roman A, Manito N, Campistol JM, Cuervas-Mons V, Almenar L, Arias M, Casafont F, del Castillo D, Crespo-Leiro MG, Delgado JF, Herrero JI, Jara P, Morales JM, Navarro M, Oppenheimer F, Prieto M, Pulpón LA, Rimola A, Serón D, Ussetti P, ATOS working group.
    Transplant Rev (Orlando); 2014 Apr 02; 28(2):84-91. PubMed ID: 24602805
    [Abstract] [Full Text] [Related]

  • 18. Effect of donor-recipient cytomegalovirus serologic status on outcomes in simultaneous kidney-pancreas transplant recipients.
    Stratta RJ, Alloway RR, Lo A, Hodge EE, PIVOT Study Group.
    Transplant Proc; 2004 May 02; 36(4):1082-3. PubMed ID: 15194376
    [Abstract] [Full Text] [Related]

  • 19. [Cytomegalovirus infection after solid-organ transplantation, its risk factors, direct and indirect effects and prevention strategies].
    Varga M, Remport A, Czebe K, Péter A, Toronyi E, Sárváry E, Fehérvári I, Sulyok B, Járay J.
    Orv Hetil; 2008 Mar 23; 149(12):551-8. PubMed ID: 18343771
    [Abstract] [Full Text] [Related]

  • 20. Cytomegalovirus infection in renal transplant recipients: one center's experience.
    Bal Z, Uyar ME, Tutal E, Erdogan E, Colak T, Sezer S, Haberal M.
    Transplant Proc; 2013 Mar 23; 45(10):3520-3. PubMed ID: 24314948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.